Women with PMOS at four-fold higher risk of heart disease

Women with polyendocrine metabolic ovarian syndrome (PMOS; also known as polycystic ovary syndrome or PCOS) face a fourfold higher risk of heart disease than women without PMOS, according to a new nationwide U.S. study published ...

FDA-issued sodium targets yield no apparent impact

In 2021, the U.S. Food and Drug Administration (FDA) issued Phase I voluntary sodium reduction targets to encourage manufacturers to lower the amount of sodium in packaged food products by 2024. The targets appear to have ...

page 1 from 40